• 68% of oncology patients experienced at least one adverse drug reaction, with hematologic toxicities being the most prevalent.
• Multidisciplinary management strategies reduced severe ADR rates by 30%, highlighting the value of proactive monitoring.
• Age, performance status, and prior treatment lines are significant risk factors for ADR development.
• Personalized treatment planning and patient education are critical to improving safety and outcomes in cancer care.